Revolutionary Non-invasive Needleless Procedure for Treating Low Back Pain ALPHARETTA, GA, UNITED STATES, November 17, 2025 / EINPresswire.com / -- FUSMobile , Inc. is proud to announce that it received De Novo marketing authorization (DEN250015) from the FDA to begin marketing and sales of the Neurolyser XR system for the non-invasive treatment of low back pain. The Neurolyser XR is a first-of-its-kind device that uses high-intensity focused ultrasound (HIFU) to non-invasiv

FUSMobile has announced that its Neurolyser XR device has been granted CE Mark for the treatment of lumbar zygapophyseal joints...

The first few participants have been enrolled in a new clinical trial investigating the safety and efficacy of using FUSMobile’s...

Use of High Intensity Focused Ultrasound (HIFU) has been lauded as an incredible therapeutic alternative for tumors, pain and other...